Evidence map›Paper›PMID 33989350›Full record

ArticlePloS one2021

Dissecting contact tracing apps in the Android platform.

Vasileios Kouliaridis, Georgios Kambourakis, Efstratios Chatzoglou, Dimitrios Geneiatakis, Hua Wang

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Mobile Apps for COVID-19: A Systematic Review of Reviews.Healthcare (Basel, Switzerland) · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Designing evaluation framework for the empirical assessment of COVID-19 mobile apps in Pakistan.Computers & electrical engineering : an international journal · 2022
    Article
  6. Article
  7. Article
  8. Do we need a contact tracing app?Computer communications · 2021
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Vasileios KouliaridisDepartment of Information & Communication Systems Engineering, University of the Aegean, Karlovasi, Greece.
Georgios KambourakisEuropean Commission, Joint Research Centre (JRC), Karlovasi, Italy.
Efstratios ChatzoglouDepartment of Information & Communication Systems Engineering, University of the Aegean, Karlovasi, Greece.ORCID 0000-0001-6507-5052
Dimitrios GeneiatakisEuropean Commission, Directorate-General for Informatics, Bruxelles/Brussel, Belgium.
Hua WangInstitute of Sustainable Industries and Liveable Cities, Victoria University, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Contact tracing has historically been used to retard the spread of infectious diseases, but if it is exercised by hand in large-scale, it is known to be a resource-intensive and quite deficient process. Nowadays, digital contact tracing has promptly emerged as an indispensable asset in the global fight against the coronavirus pandemic. The work at hand offers a meticulous study of all the official Android contact tracing apps deployed hitherto by European countries. Each app is closely scrutinized both statically and dynamically by means of dynamic instrumentation. Depending on the level of examination, static analysis results are grouped in two axes. The first encompasses permissions, API calls, and possible connections to external URLs, while the second concentrates on potential security weaknesses and vulnerabilities, including the use of trackers, in-depth manifest analysis, shared software analysis, and taint analysis. Dynamic analysis on the other hand collects data pertaining to Java classes and network traffic. The results demonstrate that while overall these apps are well-engineered, they are not free of weaknesses, vulnerabilities, and misconfigurations that may ultimately put the user security and privacy at risk.

Indexed as

Mobile ApplicationsSARS-CoV-2Computer SecurityContact TracingCOVID-19EuropeHumansPandemicsPrivacy

Identifiers

PMID33989350
PMCPMC8121305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.